← Open Payments lookup

DAVID FIGUEROA: Open Payments

NPI 1497107205 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$517 in 19 payments from 7 companies in 2025. Trend: 2023 $344 · 2024 $383 · 2025 $517

Food & beverage: $517
CompanyPaymentsAmount
Alkermes, Inc.6$239
Axsome Therapeutics, Inc.3$75
Otsuka America Pharmaceutical, Inc.3$63
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$44
Collegium Pharmaceutical, Inc.2$41
Teva Pharmaceuticals USA, Inc.2$34
Neurocrine BioSciences, Inc.1$21

Products named: ARISTADA, LYBALVI, Auvelity, CAPLYTA, Jornay PM, ABILIFY ASIMTUFII, REXULTI, INGREZZA.

Industry payments across PA — which companies pay providers there.